County of Ventura
County of Ventura was paid $17.77M by Medicaid between Jan 2018 and Dec 2024, across 124 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 65% of everything it billed.
THOUSAND OAKS, CA 91360
Next to other Federally Qualified Health Center (FQHC) providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 67,479 | $4.48M | |
| 2019 | 76,973 | $2.31M | |
| 2020 | 78,179 | $2.08M | |
| 2021 | 79,953 | $2.19M | |
| 2022 | 70,189 | $2.00M | |
| 2023 | 67,319 | $2.12M | |
| 2024incomplete | 57,252 | $2.59M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 65% | 146,554 | 133,940 | $11.56M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.6% | 128,399 | 116,898 | $1.52M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 4.5% | 1,406 | 1,400 | $808K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.1% | 31,727 | 30,195 | $557K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 40,801 | 38,538 | $350K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.2% | 4,460 | 4,455 | $215K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.2% | 5,452 | 5,441 | $212K |
| 90750 | 1.0% | 1,136 | 1,135 | $185K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.0% | 5,030 | 5,004 | $178K |
| 59425 | <1% | 2,196 | 1,375 | $165K | |
| 90651 | <1% | 3,560 | 3,550 | $134K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 3,265 | 3,250 | $113K |
112 more codes
| 20610 | <1% | 3,437 | $107K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 3,403 | $106K |
| 90686 | <1% | 9,924 | $94K | |
| 92551 | <1% | 11,578 | $91K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 647 | $88K |
| 64615 | <1% | 981 | $79K | |
| 90715 | <1% | 2,983 | $74K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,747 | $72K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 2,930 | $70K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 544 | $68K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 833 | $63K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 823 | $61K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,239 | $60K |
| 90670 | <1% | 3,407 | $49K | |
| G0467 | Community health center visit, returning patient | <1% | 13,125 | $43K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,935 | $39K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 129 | $36K |
| 90734 | <1% | 2,410 | $26K | |
| 99406 | <1% | 2,495 | $26K | |
| 90648 | <1% | 3,092 | $23K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,548 | $23K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,019 | $23K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 666 | $22K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 220 | $20K |
| 90633 | <1% | 2,150 | $18K | |
| 90620 | <1% | 508 | $18K | |
| 92250 | <1% | 317 | $18K | |
| 90710 | <1% | 1,800 | $17K | |
| 90723 | <1% | 2,102 | $17K | |
| 81002 | <1% | 11,568 | $16K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,821 | $15K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,824 | $14K |
| 0064A | <1% | 254 | $13K | |
| 82274 | <1% | 719 | $13K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,519 | $12K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 143 | $12K |
| 90677 | <1% | 283 | $12K | |
| 90680 | <1% | 1,253 | $11K | |
| 0969 | <1% | 149 | $11K | |
| 73562 | <1% | 544 | $11K | |
| 81025 | <1% | 3,090 | $10K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 794 | $10K |
| J3490 | Unclassified drugs | <1% | 506 | $8K |
| 90739 | <1% | 102 | $7K | |
| 90682 | <1% | 148 | $7K | |
| 0012A | <1% | 130 | $7K | |
| 0071A | <1% | 129 | $7K | |
| 90662 | <1% | 299 | $6K | |
| 90700 | <1% | 692 | $6K | |
| 0072A | <1% | 110 | $6K | |
| 73630 | <1% | 290 | $6K | |
| 90696 | <1% | 627 | $6K | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 183 | $5K |
| 73610 | <1% | 213 | $5K | |
| 73030 | <1% | 216 | $5K | |
| 0054A | <1% | 81 | $4K | |
| 99173 | <1% | 5,134 | $4K | |
| 17110 | <1% | 33 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 61 | $4K |
| 90837 | Psychotherapy session, about an hour | <1% | 105 | $4K |
| 90681 | <1% | 461 | $4K | |
| 90632 | <1% | 94 | $4K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 123 | $4K |
| 90732 | <1% | 43 | $3K | |
| 99442 | <1% | 195 | $3K | |
| 0011A | <1% | 59 | $3K | |
| 90678 | <1% | 13 | $3K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 438 | $3K |
| 90716 | <1% | 92 | $3K | |
| 97802 | <1% | 36 | $2K | |
| 86580 | <1% | 690 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 366 | $2K |
| 90688 | <1% | 126 | $2K | |
| 91322 | <1% | 69 | $2K | |
| 99383 | <1% | 36 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 320 | $2K |
| 72110 | <1% | 54 | $2K | |
| 99188 | <1% | 79 | $2K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 31 | $1K |
| 0004A | <1% | 25 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 103 | $1K |
| 90697 | <1% | 169 | $1K | |
| 99384 | <1% | 17 | $1K | |
| 90707 | <1% | 59 | $1K | |
| 0124A | <1% | 15 | $1K | |
| 0134A | <1% | 14 | $938.00 | |
| 73110 | <1% | 40 | $926.69 | |
| 90480 | <1% | 32 | $780.00 | |
| 72100 | <1% | 29 | $766.03 | |
| 96127 | <1% | 199 | $661.77 | |
| 90685 | <1% | 52 | $654.00 | |
| 90746 | <1% | 14 | $623.00 | |
| 99441 | <1% | 42 | $477.84 | |
| 72050 | <1% | 13 | $423.40 | |
| 73502 | <1% | 12 | $411.12 | |
| 82948 | <1% | 322 | $353.53 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 42 | $310.89 |
| 73140 | <1% | 25 | $305.58 | |
| 99201 | <1% | 108 | $281.05 | |
| 85018 | <1% | 132 | $261.17 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 15 | $155.40 |
| 69209 | <1% | 13 | $144.33 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 348 | $135.90 |
| A4649 | Surgical supply; miscellaneous | <1% | 49 | $82.94 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 96 | $82.82 |
| Z1034 | 0% | 1,623 | $0.00 | |
| 90656 | 0% | 337 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 12 | $0.00 |
| 90834 | Psychotherapy session, about 45 minutes | 0% | 20 | $0.00 |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | 0% | 15 | $0.00 |
| 0636 | 0% | 14 | $0.00 | |
| Z6400 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| County of Ventura | Ventura, CA | $136.15M |
| County of Ventura | Simi Valley, CA | $47.73M |
| County of Ventura | Ventura, CA | $32.44M |
| County of Ventura | Oxnard, CA | $21.57M |
| County of Ventura | Oxnard, CA | $17.55M |
| County of Ventura | Oxnard, CA | $15.99M |
| County of Ventura | Ventura, CA | $14.53M |
| County of Ventura | Santa Paula, CA | $12.56M |
| County of Ventura | Oxnard, CA | $12.44M |
| County of Ventura | Oxnard, CA | $9.75M |
| County of Ventura | Moorpark, CA | $7.20M |
| County of Ventura | Camarillo, CA | $5.53M |
| County of Ventura | Fillmore, CA | $5.01M |
| County of Ventura | Santa Paula, CA | $3.83M |
| County of Ventura | Oxnard, CA | $618K |
| County of Ventura | Ventura, CA | $380K |
| County of Ventura | Oxnard, CA | $24K |
| County of Ventura | Oxnard, CA | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.